Keyword: German ost-benefit agency G-BA

News

German Watchdog Says Eylea No Better Than Lucentis

17.12.2014 - Bayer's Eylea (VEGF Trap-Eye) is not more effective than its competitor Lucentis to treat patients with diabetic macular edema, the German Institute for Quality and Efficiency in...